Extended spectrum beta-lactamase urinary tract infections
Open Access
- 1 January 2014
- journal article
- Published by Medknow in Urology Annals
- Vol. 6 (2) , 114-5
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaInternational Journal Of Clinical Practice, 2012
- Antimicrobial susceptibility of global inpatient urinary tract isolates of Escherichia coli: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program: 2009–2010Diagnostic Microbiology and Infectious Disease, 2011
- Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI.2008
- Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactamsThe Journal of Infection in Developing Countries, 2007
- Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum β-lactamasesJournal of Antimicrobial Chemotherapy, 2006
- Evaluation of extended spectrum beta lactamase in urinary isolates.2004